New pill could stop prostate cancer growth for 40,000 men
A groundbreaking hormone reduction pill, which can be taken in the comfort of one’s own home, is set to benefit over 40,000 men in England who are battling advanced prostate cancer. The drug, celebrated as a potential “game-changer” for patient care, is known as Relugolix or Orgovyx and is produced by Accord. Relugolix represents a … Read more
